| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.046 | 0.7 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |